These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 37706064)

  • 1. Advances in the Study of Immunosuppressive Mechanisms in Sepsis.
    Fu X; Liu Z; Wang Y
    J Inflamm Res; 2023; 16():3967-3981. PubMed ID: 37706064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 3. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options.
    Liu D; Huang SY; Sun JH; Zhang HC; Cai QL; Gao C; Li L; Cao J; Xu F; Zhou Y; Guan CX; Jin SW; Deng J; Fang XM; Jiang JX; Zeng L
    Mil Med Res; 2022 Oct; 9(1):56. PubMed ID: 36209190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in immunotherapeutic research of sepsis].
    Dong L; Lyu J; Ding L; Liu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):184-187. PubMed ID: 28625271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune dysregulation in sepsis: experiences, lessons and perspectives.
    Cao M; Wang G; Xie J
    Cell Death Discov; 2023 Dec; 9(1):465. PubMed ID: 38114466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision Immunotherapy for Sepsis.
    Peters van Ton AM; Kox M; Abdo WF; Pickkers P
    Front Immunol; 2018; 9():1926. PubMed ID: 30233566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in sepsis - brake or accelerate?
    Steinhagen F; Schmidt SV; Schewe JC; Peukert K; Klinman DM; Bode C
    Pharmacol Ther; 2020 Apr; 208():107476. PubMed ID: 31931100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research advances of myeloid-derived suppressor cells in sepsis-induced immunosuppression].
    Peng Z; Xu J; He Y; Sun D; Shang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):666-669. PubMed ID: 35924528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms.
    Marques A; Torre C; Pinto R; Sepodes B; Rocha J
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis.
    Cao C; Yu M; Chai Y
    Cell Death Dis; 2019 Oct; 10(10):782. PubMed ID: 31611560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of human ghrelin and growth hormone: Attenuation of immunosuppression in septic aged rats.
    Zhou M; Yang WL; Aziz M; Ma G; Wang P
    Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt B):2584-2593. PubMed ID: 28115288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: Potential targets for nafamostat mesilate.
    He Q; Wei Y; Qian Y; Zhong M
    J Intensive Med; 2024 Oct; 4(4):453-467. PubMed ID: 39310056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?
    Leentjens J; Kox M; van der Hoeven JG; Netea MG; Pickkers P
    Am J Respir Crit Care Med; 2013 Jun; 187(12):1287-93. PubMed ID: 23590272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis-Induced Immunosuppression.
    Torres LK; Pickkers P; van der Poll T
    Annu Rev Physiol; 2022 Feb; 84():157-181. PubMed ID: 34705481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving Paradigms in Sepsis Management: A Narrative Review.
    Kim MJ; Choi EJ; Choi EJ
    Cells; 2024 Jul; 13(14):. PubMed ID: 39056754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomodulation for sepsis: a change of tack?].
    Leentjens J; Kox M; Pickkers P
    Ned Tijdschr Geneeskd; 2014; 158():A6859. PubMed ID: 24518844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Damage-Associated Molecular Patterns As Double-Edged Swords in Sepsis.
    Zhou M; Aziz M; Wang P
    Antioxid Redox Signal; 2021 Nov; 35(15):1308-1323. PubMed ID: 33587003
    [No Abstract]   [Full Text] [Related]  

  • 19. MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets.
    Zhang W; Fang X; Gao C; Song C; He Y; Zhou T; Yang X; Shang Y; Xu J
    Cytokine Growth Factor Rev; 2023 Feb; 69():90-103. PubMed ID: 35927154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.
    Yao RQ; Ren C; Zheng LY; Xia ZF; Yao YM
    Front Immunol; 2022; 13():891024. PubMed ID: 35619710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.